to evaluate novel potentially protective vaccines to identify new candidate vaccines for future clinical testing for SARS-CoV-2 prevention
- Funded by Gates Foundation
- Total publications:0 publications
Grant number: INV-019081
Grant search
Key facts
Disease
COVID-19Start & end year
2020Known Financial Commitments (USD)
$574,923Funder
Gates FoundationResearch Location
United States of AmericaLead Research Institution
Gritstone bio, Inc.Research Priority Alignment
N/A
Research Category
Vaccines research, development and implementationResearch Subcategory
Pre-clinical studiesSpecial Interest Tags
N/AStudy Type
UnspecifiedClinical Trial Details
N/ABroad Policy Alignment
PendingAge Group
UnspecifiedVulnerable Population
UnspecifiedOccupations of Interest
Unspecified
Abstract
N/A